Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
0.930
+0.008 (0.87%)
Jul 7, 2022 9:31 AM EDT - Market open

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Year 202020192018
Cash & Equivalents
1.930.090.04
Short-Term Investments
00.10.21
Cash & Cash Equivalents
1.930.190.25
Cash Growth
909.03%-23.06%-
Other Current Assets
0.981.621.25
Total Current Assets
2.911.811.5
Total Assets
2.911.811.5
Accounts Payable
0.560.991.18
Current Debt
0.3400
Total Current Liabilities
0.90.991.18
Total Liabilities
0.90.991.18
Total Debt
0.3400
Common Stock
18.8512.617.69
Retained Earnings
-16.83-11.79-7.38
Shareholders' Equity
2.010.820.32
Total Liabilities and Equity
2.911.811.5
Net Cash / Debt
1.590.190.25
Net Cash / Debt Growth
733.66%-23.06%-
Net Cash Per Share
0.020.000.00
Working Capital
2.010.820.32
Book Value Per Share
0.030.010.01
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).